CD8+ T cells, though critical for tumor cell lysis via IFN-γ and granzyme secretion, are often hindered by checkpoint molecules like CTLA-4 and PD-1, contributing to variable survival outcomes [106,107]. The gene discussed is IFNG; the disease is neoplasm.